Craft
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
banner
Zhejiang Huahai Pharmaceutical financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.

Stock Price

¥18.8

2024-10-29

Market Capitalization

¥27.1 B

2024-10-29

Revenue

¥8.4 B

FY, 2025

CreditSafe Score

?
Score changed on Jun 12, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn more

Financial Statements

CNYFY, 2018FY, 2019FY, 2020FY, 2021FY, 2022FY, 2023FY, 2024FY, 2025
Revenue5.0B5.3B6.4B6.5B8.1B8.2B9.4B8.4B
Cost of goods sold2.1B2.1B2.4B2.7B3.1B3.3B3.6B3.4B
Gross profit3.0B3.2B4.1B3.9B5.1B4.9B5.8B5.1B
Gross profit margin, %60.4%63.7%60.0%62.6%60.4%61.8%60.0%
Operating expense total2.2B1.9B2.1B2.8B2.7B2.8B3.2B3.4B
Depreciation and amortization356.0M425.5M473.6M553.9M677.9M808.2M929.4M1.0B
EBITDA809.2M1.3B1.9B1.1B2.3B2.1B2.6B1.7B
EBITDA margin, %24.4%29.7%16.6%28.3%26.1%27.4%19.7%
EBIT347.4M958.9M1.5B828.0M1.6B1.3B1.6B673.2M
EBIT margin, %18.1%23.5%12.7%19.4%15.9%16.9%8.0%
Interest income6.9M20.8M19.6M33.5M25.8M39.5M53.2M25.8M
Interest expense139.8M224.7M135.3M166.3M220.0M231.7M219.8M233.6M
Pre tax profit157.2M760.9M1.2B786.9M1.5B1.1B1.5B443.9M
Income tax expense22.3M154.0M220.8M306.3M332.9M283.1M356.1M216.5M
Net Income134.9M606.8M994.6M480.6M1.2B817.2M1.1B227.3M

Footer menu